Literature DB >> 25567531

Enrichment of Human Stem-Like Prostate Cells with s-SHIP Promoter Activity Uncovers a Role in Stemness for the Long Noncoding RNA H19.

Hélène Bauderlique-Le Roy1, Constance Vennin, Guillaume Brocqueville, Nathalie Spruyt, Eric Adriaenssens, Roland P Bourette.   

Abstract

Understanding normal and cancer stem cells should provide insights into the origin of prostate cancer and their mechanisms of resistance to current treatment strategies. In this study, we isolated and characterized stem-like cells present in the immortalized human prostate cell line, RWPE-1. We used a reporter system with green fluorescent protein (GFP) driven by the promoter of s-SHIP (for stem-SH2-domain-containing 5'-inositol phosphatase) whose stem cell-specific expression has been previously shown. We observed that s-SHIP-GFP-expressing RWPE-1 cells showed stem cell characteristics such as increased expression of stem cell surface markers (CD44, CD166, TROP2) and pluripotency transcription factors (Oct4, Sox2), and enhanced sphere-forming capacity and resistance to arsenite-induced cell death. Concomitant increased expression of the long noncoding RNA H19 was observed, which prompted us to investigate a putative role in stemness for this oncofetal gene. Targeted suppression of H19 with siRNA decreased Oct4 and Sox2 gene expression and colony-forming potential in RWPE-1 cells. Conversely, overexpression of H19 significantly increased gene expression of these two transcription factors and the sphere-forming capacity of RWPE-1 cells. Analysis of H19 expression in various prostate and mammary human cell lines revealed similarities with Sox2 expression, suggesting that a functional relationship may exist between H19 and Sox2. Collectively, we provide the first evidence that s-SHIP-GFP promoter reporter offers a unique marker for the enrichment of human stem-like cell populations and highlight a role in stemness for the long noncoding RNA H19.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25567531      PMCID: PMC4425227          DOI: 10.1089/scd.2014.0386

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  56 in total

1.  LincRNAs join the pluripotency alliance.

Authors:  Jia-Hui Ng; Huck-Hui Ng
Journal:  Nat Genet       Date:  2010-12       Impact factor: 38.330

2.  Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2.

Authors:  W M Kavanaugh; D A Pot; S M Chin; M Deuter-Reinhard; A B Jefferson; F A Norris; F R Masiarz; L S Cousens; P W Majerus; L T Williams
Journal:  Curr Biol       Date:  1996-04-01       Impact factor: 10.834

3.  Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal.

Authors:  Yue Wang; Zhenyu Xu; Junfeng Jiang; Chen Xu; Jiuhong Kang; Lei Xiao; Minjuan Wu; Jun Xiong; Xiaocan Guo; Houqi Liu
Journal:  Dev Cell       Date:  2013-03-28       Impact factor: 12.270

4.  s-SHIP associates with receptor complexes essential for pluripotent stem cell growth and survival.

Authors:  C Desponts; J M Ninos; W G Kerr
Journal:  Stem Cells Dev       Date:  2006-10       Impact factor: 3.272

5.  Parental imprinting of the mouse H19 gene.

Authors:  M S Bartolomei; S Zemel; S M Tilghman
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

6.  Neuregulin-3 regulates epithelial progenitor cell positioning and specifies mammary phenotype.

Authors:  Naoko Kogata; Erik Oliemuller; Olivia Wansbury; Beatrice A Howard
Journal:  Stem Cells Dev       Date:  2014-08-11       Impact factor: 3.272

7.  H19 and insulin-like growth factor-II gene expression in adrenal tumors and cultured adrenal cells.

Authors:  J Liu; A I Kahri; P Heikkilä; V Ilvesmäki; R Voutilainen
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

8.  Oncofetal H19 RNA promotes tumor metastasis.

Authors:  Imad J Matouk; Eli Raveh; Rasha Abu-lail; Shaul Mezan; Michal Gilon; Eitan Gershtain; Tatiana Birman; Jennifer Gallula; Tamar Schneider; Moshe Barkali; Carmelit Richler; Yakov Fellig; Vladimir Sorin; Ayala Hubert; Abraham Hochberg; Abraham Czerniak
Journal:  Biochim Biophys Acta       Date:  2014-04-02

9.  Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability.

Authors:  Changyong Guo; Haibo Liu; Bao-Hui Zhang; Radu M Cadaneanu; Aqila M Mayle; Isla P Garraway
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

10.  Aldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activity.

Authors:  Kalyan J Gangavarapu; Gissou Azabdaftari; Carl D Morrison; Austin Miller; Barbara A Foster; Wendy J Huss
Journal:  Stem Cell Res Ther       Date:  2013-10-25       Impact factor: 6.832

View more
  27 in total

Review 1.  The emerging role of lncRNAs in the regulation of cancer stem cells.

Authors:  Rosario Castro-Oropeza; Jorge Melendez-Zajgla; Vilma Maldonado; Karla Vazquez-Santillan
Journal:  Cell Oncol (Dordr)       Date:  2018-09-14       Impact factor: 6.730

Review 2.  Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy?

Authors:  Hidetaka Shima; Akimitsu Yamada; Takashi Ishikawa; Itaru Endo
Journal:  Gland Surg       Date:  2017-02

3.  Transcription factor Oct4 promotes osteosarcoma by regulating lncRNA AK055347.

Authors:  Hongwu Fan; Guangyao Liu; Changfu Zhao; Xuefeng Li; Xiaoyu Yang
Journal:  Oncol Lett       Date:  2016-11-21       Impact factor: 2.967

Review 4.  Signaling Pathways and Targeted Therapies for Stem Cells in Prostate Cancer.

Authors:  Madhuvanthi Giridharan; Vasu Rupani; Satarupa Banerjee
Journal:  ACS Pharmacol Transl Sci       Date:  2022-03-30

Review 5.  Long non-coding RNAs in genitourinary malignancies: a whole new world.

Authors:  Ronan Flippot; Guillaume Beinse; Alice Boilève; Julien Vibert; Gabriel G Malouf
Journal:  Nat Rev Urol       Date:  2019-08       Impact factor: 14.432

Review 6.  The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision.

Authors:  Imad J Matouk; David Halle; Eli Raveh; Michal Gilon; Vladimir Sorin; Avraham Hochberg
Journal:  Oncotarget       Date:  2016-01-26

7.  s-SHIP expression identifies a subset of murine basal prostate cells as neonatal stem cells.

Authors:  Guillaume Brocqueville; Renee S Chmelar; Hélène Bauderlique-Le Roy; Emeric Deruy; Lu Tian; Robert L Vessella; Norman M Greenberg; Larry R Rohrschneider; Roland P Bourette
Journal:  Oncotarget       Date:  2016-05-17

Review 8.  Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism.

Authors:  Jing-Wen Shih; Ling-Yu Wang; Chiu-Lien Hung; Hsing-Jien Kung; Chia-Ling Hsieh
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

Review 9.  The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory.

Authors:  Eli Raveh; Imad J Matouk; Michal Gilon; Abraham Hochberg
Journal:  Mol Cancer       Date:  2015-11-04       Impact factor: 27.401

10.  The knockdown of H19lncRNA reveals its regulatory role in pluripotency and tumorigenesis of human embryonic carcinoma cells.

Authors:  Evelyne Zeira; Rinat Abramovitch; Karen Meir; Sharona Even Ram; Yaniv Gil; Baruch Bulvik; Zohar Bromberg; Or Levkovitch; Nathalie Nahmansson; Revital Adar; Benjamin Reubinoff; Eithan Galun; Michal Gropp
Journal:  Oncotarget       Date:  2015-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.